one
import
function
cellular
metabol
protein
fold
endoplasm
reticulum
er
site
protein
secret
membran
bound
organel
target
protein
typic
process
fold
eukaryot
kaufman
et
al
naidoo
accumul
high
concentr
protein
er
lead
coaggreg
protein
andor
polypeptid
steven
argon
therefor
lumen
er
need
uniqu
environ
promot
process
protein
prevent
aggreg
anelli
sitia
kim
et
al
hetz
et
al
hetz
sometim
due
high
demand
protein
synthesi
due
variou
physiolog
reason
process
capac
er
challeng
zhang
kaufman
marcinak
ron
hetz
et
al
result
imbal
er
environ
refer
er
stress
liu
howel
marcinak
ron
hetz
et
al
iwata
koizumi
alter
protein
fold
lead
er
stress
induc
variou
factor
glucos
depriv
aberr
calcium
regul
viral
infect
hypoxia
normal
cell
ensur
protein
correctli
fold
use
combin
molecular
chaperon
name
foldas
lectin
naidoo
unfold
misfold
protein
continu
accumul
eukaryot
induc
upr
basic
goal
upr
recov
lost
homeostasi
adapt
reduc
stress
within
er
compart
prevent
cytotox
effect
might
caus
misfold
protein
via
adapt
mechan
well
block
mrna
translat
xu
et
al
kim
et
al
ye
et
al
adapt
upr
tri
correct
fold
homeostasi
via
induct
chaperon
promot
protein
fold
meusser
et
al
kim
et
al
howev
proper
fold
restor
incorrectli
fold
protein
target
er
associ
degrad
erad
pathway
process
kaufman
et
al
upr
also
known
trigger
sever
molecul
innat
immun
pathway
notabl
mitogen
activ
protein
kinas
nuclear
b
b
collect
trigger
upr
induc
alarm
signal
ron
walter
kim
et
al
taba
ron
remov
translat
block
downregul
express
activ
prosurviv
factor
bcell
lymphoma
protein
howev
function
er
reestablish
upr
elimin
damag
cell
apoptosi
autophagi
bernal
et
al
kamimoto
et
al
yorimitsu
et
al
hoyerhansen
et
al
kouroku
et
al
apart
respons
de
novo
synthes
protein
cell
massiv
accumul
exogen
protein
intracellularli
case
viral
infect
also
known
contribut
er
stress
respons
pathway
zhang
wang
viru
success
infect
mammalian
cell
undergo
sever
aspect
lifecycletheir
attach
cell
surfac
receptor
endocytosi
intracellular
traffick
polypeptid
synthesi
genom
replic
balakrishnan
jayandharan
virus
natur
evolv
util
host
cell
machineri
success
complet
life
cycl
process
produc
sever
viral
protein
within
host
cell
natur
respons
foreign
protein
cell
turn
activ
upr
interferon
respons
thu
potenti
mechan
limit
viral
replic
upr
surpris
virus
also
evolv
mechan
manipul
upr
pathway
facilit
infect
zhang
wang
gener
involv
regul
stress
respons
protein
sever
molecular
chaperon
modul
upr
increas
er
fold
capac
induct
translat
attenu
repress
upr
pathway
zhang
wang
sever
virus
like
adenoviru
ad
adenoassoci
viru
aav
dengu
viru
cytomegaloviru
respiratori
syncyti
viru
simian
tula
viru
rota
viru
african
swine
fever
viru
herp
simplex
viru
type
hepat
c
viru
corona
viru
influenza
viru
amongst
other
shown
regul
host
cell
upr
machineri
promot
infect
persist
host
bitko
barik
netherton
et
al
isler
et
al
paradkar
et
al
pena
harri
zhang
wang
exampl
rotaviru
interrupt
inositol
requir
activ
transcript
factor
upr
pathway
translat
inhibit
nonstructur
protein
trujilloalonso
et
al
hepat
c
viru
hcv
shown
suppress
pathway
promot
express
persist
liver
tardif
et
al
likewis
cytomegaloviru
use
viral
protein
downregul
lead
suppress
upr
stahl
et
al
articl
review
tug
war
initi
cell
upr
signal
virus
use
gene
therapi
dissect
inform
help
improv
gene
deliveri
strategi
evolutionarili
conserv
branch
upr
cox
et
al
initi
prosurviv
proapoptot
compon
presenc
misfold
protein
mammal
two
isoform
identifi
express
varieti
tissu
tirasophon
et
al
wherea
primarili
found
intestin
lung
bertolotti
et
al
martino
et
al
mechanist
increas
unfold
misfold
protein
load
bip
molecul
interact
nterminu
locat
er
lumen
sens
lead
dimer
activ
two
distinct
signal
arm
pathway
earli
signal
occur
cleavag
intron
shen
et
al
yoshida
et
al
lee
et
al
malhotra
kaufman
gener
kda
frameshift
variant
act
potent
transcript
factor
regul
express
sever
protein
degrad
relat
gene
rao
bredesen
malhotra
kaufman
late
signal
sensor
initi
cytosol
dimer
interact
molecul
like
tumor
necrosi
factor
receptorassoci
factor
activ
signalregul
kinas
activ
cjun
kinas
jnk
urano
et
al
protein
turn
trigger
proapoptot
signal
proapoptot
molecul
bim
lead
cell
death
perk
erloc
type
transmembran
protein
contain
catalyt
kinas
domain
homolog
kinas
eukaryot
translat
initi
factor
gener
control
hemeregul
inhibitor
hri
protein
kinas
r
pkr
hard
et
al
lumin
stress
sensor
domain
perk
structur
function
homolog
lumin
domain
implic
similar
stresssens
mechan
perk
bertolotti
et
al
perk
branch
upr
transduc
prosurviv
well
proapoptot
signal
follow
accumul
unfold
misfold
protein
er
howev
main
function
modul
translat
initi
stage
er
stress
perk
oligomer
er
membran
induc
autophosphoryl
activ
perk
phosphoryl
hard
et
al
raven
et
al
lead
global
attenu
translat
machineri
thu
reduc
traffick
newli
synthes
protein
alreadi
stress
er
compart
accumul
protein
load
clear
er
erad
pathway
simultan
express
prosurviv
gene
like
activ
transcript
factor
hard
et
al
affect
global
translat
block
presenc
intern
ribosom
entri
site
ire
sequenc
untransl
region
schroder
kaufman
howev
drive
cell
toward
apoptosi
induc
express
factor
like
cebp
homolog
protein
chop
growth
arrest
dna
damageinduc
protein
zinszner
et
al
novoa
et
al
type
ii
er
transmembran
protein
belong
bzip
famili
transcript
factor
er
lumin
domain
act
sensor
er
stress
due
protein
overload
cytoplasm
domain
act
transcript
factor
two
homolog
hai
et
al
haze
et
al
min
et
al
khanna
campbel
haze
et
al
redund
role
upr
upon
dissoci
bip
nterminu
follow
er
stress
transloc
er
golgi
cleav
resid
proteas
like
site
proteas
site
proteas
hetz
et
al
releas
cytoplasm
dna
bind
fragment
call
increas
degrad
unfold
protein
well
induc
activ
sever
er
chaperon
protein
like
bip
protein
disulfid
isomeras
pdi
er
degradationenhanc
alphamannosidaselik
protein
wu
et
al
yamamoto
et
al
larg
kb
fast
replic
envelop
doubl
strand
ds
dna
viru
matur
viral
particl
consist
compon
extern
envelop
made
glycoprotein
help
viru
bind
enter
host
cell
second
layer
call
tegument
contain
differ
structur
regulatori
protein
final
icosohedr
capsid
contain
genet
materi
hsv
attract
choic
gene
therapi
vector
variou
reason
includ
broad
tropism
host
rang
cellular
receptor
arii
et
al
fan
et
al
wang
et
al
abil
infect
nondivid
cell
high
effici
high
product
titer
recombin
particl
stablelongterm
express
therapeut
gene
especi
neuron
norgren
lehman
three
type
vector
current
use
gene
therapi
replicationdefect
replicationcompet
vector
amplicon
delet
one
gene
involv
lytic
cycl
creat
replicationdefect
vector
replicationcompet
virus
attenu
gene
essenti
replic
vitro
hu
coffin
post
et
al
amplicon
deriv
engin
plasmid
contain
hsv
packag
recognit
sequenc
pac
origin
replic
ori
amplicon
effici
packag
mammalian
cell
concatam
help
hsv
helper
element
also
amplicon
nontox
carri
larg
dna
fragment
upto
kb
epstein
replic
defect
replic
compet
hsv
vector
use
gene
therapi
sever
neurolog
disord
tabl
replic
defect
hsv
vector
shown
effici
transduc
divid
nondivid
cell
includ
tumor
take
advantag
properti
hsv
vector
engin
deliv
anticanc
transgen
tumour
cell
melanoma
kriski
et
al
niranjan
et
al
gliosarcoma
moriuchi
et
al
niranjan
et
al
glioblastoma
niranjan
et
al
one
major
factor
neg
affect
hsv
mediat
gene
deliveri
host
immun
respons
direct
includ
innat
adapt
respons
ryan
federoff
first
line
defens
innat
immun
major
ratelimit
factor
hsv
transduct
one
princip
effector
underli
antihsv
innat
defens
process
autophagi
initi
cellular
upr
pathway
lee
et
al
replic
hsv
rapid
gener
larg
amount
viral
protein
may
induc
upr
consequ
necessit
modul
cellular
stress
respons
figur
inde
number
protein
shown
block
phosphoryl
import
stress
respons
mechan
cell
lead
attenu
protein
synthesi
et
al
cassadi
et
al
mulvey
et
al
cassadi
et
al
mulvey
et
al
show
hsv
viral
protein
repress
two
kinas
pkr
perk
upon
hsv
infect
figur
cassadi
et
al
mulvey
et
al
et
al
demonstr
late
protein
dephosphoryl
help
cellular
phosphatas
et
al
inhibit
result
increas
replic
effici
talloczi
et
al
shown
infect
activ
perk
well
ire
also
highli
resist
acut
er
stress
mulvey
et
al
resist
perk
toward
activ
er
stress
infect
cell
attribut
glycoprotein
b
gb
associ
lumin
region
perk
figur
studi
also
show
genet
associ
perk
gb
could
regul
viral
protein
load
infect
cell
mulvey
et
al
understand
modul
cellular
upr
burnett
et
al
report
deactiv
upr
earli
stage
infect
burnett
et
al
studi
observ
earli
repress
less
h
post
infect
chop
due
inhibit
phosphoryl
immediateearli
ad
gene
product
known
transcript
factor
capabl
yao
schaffer
found
primari
factor
trigger
activ
upr
enhanc
replic
thu
help
viru
sens
earli
stage
consist
previou
find
mulvey
et
al
signal
pathway
remain
inact
studi
well
ad
nonenvelop
dna
virus
whose
genom
compris
linear
kb
doublestrand
dna
recombin
ad
vector
first
use
gene
transfer
agent
ballay
et
al
yamada
et
al
sinc
use
vehicl
variou
monogen
diseas
porteu
et
al
exampl
ad
vector
express
cystic
fibrosi
transmembran
conduct
regul
cftr
use
phase
clinic
studi
treat
cystic
fibrosi
zuckerman
et
al
muscular
dystrophi
anoth
diseas
attenu
ad
vector
use
deliv
dystrophin
cdna
muscl
tissu
clemen
et
al
haecker
et
al
floyd
et
al
improv
ad
vector
also
use
deliv
human
coagul
factor
viii
ix
phenotyp
correct
hemophilia
preclin
anim
model
zhang
vector
use
treatment
sever
metabol
genet
diseas
like
lysosom
storag
diseas
phenylketonuria
glycogen
storag
diseas
amalfitano
et
al
nagasaki
et
al
ziegler
et
al
eto
ohashi
stein
et
al
zingon
et
al
neurolog
disord
like
parkinsonalzheim
well
cardiovascular
diseas
like
atherosclerosi
cerebr
ischemia
cancer
therapi
donahu
et
al
papadopoulo
et
al
choi
yun
case
foreign
protein
ad
vector
also
subject
sever
inflammatori
respons
lead
clearanc
achiev
transient
gene
express
target
tissu
one
major
transcript
factor
serv
mediat
inflammatori
respons
b
activ
variou
patholog
stimuli
like
bacterialvir
infect
inflammatori
cytokin
shown
previous
accumul
protein
load
er
activ
b
via
perk
pathway
tam
et
al
demonstr
ad
k
protein
activ
b
mediat
releas
er
follow
protein
overload
vitro
result
b
activ
inflammatori
cytokin
interferon
constitut
initi
antivir
respons
cell
pahl
baeuerl
virus
late
phase
product
infect
viral
protein
synthesi
promot
adinfect
cell
simultan
inhibit
cellular
protein
synthesi
one
way
ad
inhibit
pkrmediat
phosphoryl
along
activ
protein
kinas
call
doublestrand
rnaactiv
inhibitor
dai
huang
schneider
also
shown
noncod
ad
associ
rna
molecul
vai
rna
suppress
pkr
activ
directli
bind
mathew
shenk
mckenna
et
al
vai
rna
highli
express
late
phase
ad
infect
transcrib
rna
polymeras
iii
soderlund
et
al
thimmappaya
et
al
svensson
akusjarvi
play
crucial
role
prevent
shutdown
cellular
translat
apparatu
inhibit
phosphoryl
activ
pkr
although
precis
mechan
remain
unclear
huang
schneider
spergeon
et
al
also
shown
role
ad
open
read
frame
protein
promot
infect
late
phase
ad
protein
shown
limit
phosphoryl
phosphoryl
pkr
activ
figur
process
requir
function
ubiquitinprotein
ligas
complex
independ
cytoplasm
level
vai
rna
spurgeon
ornel
natur
occur
aav
small
nm
nonenvelop
contain
singlestrand
dna
kb
belong
famili
parvovirida
genu
dependoviru
balakrishnan
jayandharan
genom
contain
two
open
read
frame
encod
gene
rep
respons
replic
cap
encod
capsid
specif
protein
flank
base
pair
long
invert
termin
repeat
itr
sequenc
aav
enter
infect
cycl
presenc
helper
viru
ad
hsv
daya
bern
recombin
aav
produc
stuf
transgen
interest
flank
itr
rep
cap
gene
suppli
tran
along
helper
function
gene
wright
current
aav
choic
vector
mani
inherit
noninherit
diseas
nonpathogen
natur
anoth
major
advantag
use
aav
gene
therapi
vector
low
immun
profil
compar
ad
vector
asokan
et
al
far
aav
serotyp
use
gene
therapi
vector
although
sever
serovar
known
exist
aav
natur
hepatotroph
make
attract
choic
liver
target
gene
therapi
treatment
diseas
hemophilia
antitrypsin
defici
flott
et
al
nathwani
et
al
howev
sever
altern
serotyp
like
shown
signific
promis
target
tissu
like
muscl
central
nervou
system
zincarelli
et
al
tang
et
al
rafi
et
al
gray
et
al
unfortun
vector
dosedepend
immun
respons
presenc
preexist
neutral
antibodi
aav
capsid
limit
persist
gene
express
human
manno
et
al
boutin
et
al
known
aav
receptor
mediat
endcocytosi
undergo
traffick
endocyt
compart
follow
retrograd
transport
golgi
er
ding
et
al
shown
earlier
intracellular
traffick
aav
neg
regul
compon
er
stress
respons
duan
et
al
douar
et
al
ding
et
al
exampl
aav
mediat
human
factor
f
viii
gene
express
improv
upon
inhibit
proteasom
machineri
use
pharmacolog
agent
like
bortezomib
preclin
anim
model
haemophilia
monahan
et
al
thu
quit
logic
note
intracellular
traffick
er
stress
could
play
inhibitori
role
aav
life
cycl
inde
recent
shown
role
upr
aav
infect
balakrishnan
et
al
studi
selfcomplementari
sc
shown
activ
perk
pathway
hela
cell
peak
activ
h
postinfect
howev
induc
interestingli
singlestrand
ss
induc
upr
effector
dominantli
although
modestli
activ
perk
activ
perk
confirm
increas
express
downstream
signal
molecul
like
chop
splice
respect
inhibit
perk
express
vitro
use
shrna
vivo
metformin
ip
led
modest
increas
gene
express
vector
figur
interestingli
studi
also
found
altern
aav
serotyp
vector
like
activ
distinct
arm
upr
exampl
compar
effect
perk
activ
vector
anoth
observ
ablat
innat
immun
respons
marker
follow
upr
inhibit
vivo
clearli
point
link
upr
activ
clear
vector
innat
immun
respons
shown
previous
aav
activ
classic
b
pathway
acut
phase
infect
trigger
downstream
inflammatori
marker
like
lead
activ
adapt
immun
respons
jayandharan
et
al
also
known
upr
caus
protein
overload
activ
cellular
b
earli
phase
inhibitori
late
phase
kitamura
figur
thu
upr
pathway
becom
import
target
reduc
inflammatori
respons
earli
stage
aav
infect
enhanc
persist
gene
express
aav
vector
interestingli
effici
aav
transduct
also
known
improv
gener
cellular
stress
shown
earlier
cellular
model
cystic
fibrosi
johnson
et
al
histor
vector
base
retroviru
first
viral
vector
system
describ
earli
douar
et
al
prefer
clinic
gene
therapi
due
properti
effici
host
dna
integr
persist
gene
express
howev
clinic
trial
involv
infant
xscid
patient
develop
leukemia
due
random
retrovir
integr
remain
major
concern
retroviru
base
gene
therapi
cavazzanacalvo
et
al
kohn
et
al
lentiviru
belong
retrovirida
famili
also
known
facilit
stabl
integr
viral
genom
host
chromosom
past
decad
patient
differ
immunodefici
disord
treat
success
use
murin
leukemia
viru
mlv
base
vector
transfer
therapeut
gene
autolog
hematopoiet
cell
aiuti
et
al
aiuti
roncarolo
howev
random
integr
lentivir
vector
also
known
wang
et
al
although
mani
studi
conduct
understand
retro
lentivirus
combat
upr
evid
retrovirus
induc
er
stress
shikova
et
al
first
show
cultur
astrocyt
neuropathogen
mlv
virus
may
relat
protein
misfold
er
shikova
et
al
dimcheff
et
al
demonstr
mous
retroviru
frcase
abl
induc
er
stress
relat
gene
like
bip
vitro
cell
well
vivo
correl
induct
spongiform
neurodegener
figur
dimcheff
et
al
similarli
mink
cell
focusform
murin
leukemia
viru
mlv
shown
trigger
upr
mink
cell
follow
larg
accumul
viral
protein
mlv
via
upregul
chop
protein
nanua
yoshimura
protein
call
transactiv
transcript
tat
report
induc
upr
increas
reactiv
oxygen
speci
ro
primari
rat
striatal
neuron
indic
er
stress
respons
could
critic
paramet
control
hiv
infect
figur
tied
et
al
anoth
hiv
viral
protein
call
nef
known
increas
infect
replic
lymphocyt
macrophag
shown
directli
interact
eukaryot
elong
factor
eef
result
cytoplasm
reloc
inhibit
stressinduc
apoptosi
convers
nuclear
reloc
complex
decreas
mitochondri
cytochrom
c
releas
therebi
inhibit
caspas
activ
mechan
demonstr
lentiviru
hiv
prevent
cell
death
condit
stress
condit
yet
abl
creat
environ
favor
optim
viral
replic
abba
et
al
figur
anoth
uniqu
retroviru
call
foami
virus
fv
also
extens
studi
gene
therapi
vector
due
lack
pathogen
broad
tissu
tropism
abil
carri
larg
minimum
kb
transgen
henein
et
al
trobridg
hematopoiet
stem
cell
hsc
gene
therapi
one
area
fv
extens
evalu
consider
success
josephson
et
al
bauer
et
al
howev
publish
evid
studi
interact
fv
cellular
upr
howev
possibl
like
retrolenti
virus
fv
would
develop
mechan
either
counteract
util
upr
machineri
enhanc
replic
infect
cell
addit
commonli
use
viral
vector
describ
attempt
made
util
virus
vector
certain
diseas
condit
exampl
vaccinia
viral
vector
use
potenti
therapeut
cancer
gene
therapi
yu
et
al
seubert
et
al
mainli
effici
infect
gene
express
wide
rang
difficult
transduc
tumor
yu
et
al
well
inabl
integr
chromosom
shen
nemuna
also
safeti
profil
vaccinia
viru
therapeut
agent
well
understood
due
long
widespread
use
vaccin
small
pox
human
like
virus
vaccinia
viru
also
regul
cellular
upr
machineri
facilit
infect
exampl
vaccinia
viral
protein
sequenc
ident
thought
function
pseudo
substrat
kinas
thu
block
pkr
activ
lead
inhibit
perk
molecul
sood
et
al
follow
er
stress
respons
anoth
vaccinia
protein
call
indirectli
inhibit
activ
apoptot
protein
baxbi
interact
proapoptot
protein
bak
bax
taylor
et
al
varicella
zoster
viru
vzv
caus
agent
varicella
chickenpox
zoster
shingl
member
herpesvirida
famili
also
test
cancer
gene
therapi
vector
degrev
et
al
vzv
shown
induc
cellular
upr
er
stress
vitro
shown
activ
chop
pathway
ultim
lead
autophagi
carpent
et
al
studi
also
confirm
vzv
structur
gi
gh
gl
enough
induc
upr
activ
viral
infect
viru
ebv
member
herpesvirida
famili
natur
tropism
b
cell
properti
viru
util
deliv
gmcsf
human
b
cell
bcell
chronic
lymphocyt
leukemia
bcll
patient
potenti
immun
therapi
hellebrand
et
al
howev
sinc
ebv
associ
number
human
malign
rigor
vector
modif
valid
call
prior
applic
gene
deliveri
vehicl
human
latent
membran
protein
oncogen
ebv
shown
induc
phosphoryl
activ
three
arm
upr
perk
pathway
activ
turn
upregul
lead
induct
mainten
prolifer
b
lymphocyt
lee
sugden
thu
seem
upr
pathway
requir
ebv
enter
lytic
stage
toward
maintain
prolif
infecti
lifecycl
taylor
et
al
sendai
viru
sev
neg
strand
rna
viru
util
sialic
acid
residu
sialoglycoprotein
receptor
cell
entri
markwel
et
al
major
advantag
use
recombin
sev
gene
therapi
vector
nonpathogen
abil
gener
high
titr
packag
process
preclin
studi
shown
sev
transduc
differ
cell
type
like
vascular
tissu
masaki
et
al
skelet
muscl
shiotani
et
al
airway
epitheli
cell
yonemitsu
et
al
synovi
cell
yamashita
et
al
quit
effici
shown
sev
vector
effici
transfer
cargo
cell
cell
subpopul
deriv
human
cord
blood
jin
et
al
addit
sev
also
abl
get
stabl
gene
express
myeloid
erythroid
mix
progenitor
cell
jin
et
al
howev
sinc
sev
induc
cytopath
effect
infect
cell
toxic
concern
remain
sev
shown
upregul
protein
follow
er
stress
lead
cell
death
via
activ
mediat
apoptosi
bitzer
et
al
versteeg
et
al
also
thought
viru
activ
kinas
like
perk
pkr
induc
ifn
regulatori
factor
irf
major
player
host
antivir
innat
respons
anoth
key
regul
cellular
respons
viral
infect
upregul
via
phosphoryl
activ
ultim
help
cellular
recoveri
liang
et
al
alphaviru
vector
base
sindbisviru
sinv
semliki
forest
viru
sfv
anoth
group
viru
evalu
gene
therapi
vector
advantag
like
broad
host
rang
effici
replic
cytoplasm
capac
produc
high
level
recombin
protein
sever
preclin
studi
conduct
far
evalu
effici
alphavirus
gene
transfer
vehicl
exampl
sfv
shown
transduc
cardiovascular
cell
well
human
tumor
cell
deliv
rok
et
al
zhang
et
al
alphavir
vector
also
look
upon
potenti
deliveri
vehicl
dnabas
vaccin
berglund
et
al
recent
sfv
use
gene
transfer
central
nervou
system
also
toxic
graham
et
al
mammalian
cell
sfv
envelop
glycoprotein
activ
upr
respons
induct
chop
protein
consequ
upregul
apoptot
enzym
barri
et
al
sfv
also
shown
delay
rna
synthesi
presenc
brefeldin
potent
upr
induc
molina
et
al
anoth
report
suggest
perk
suppress
sfv
viral
replic
earli
stage
elicit
strong
interferon
respons
mous
brain
barri
et
al
one
studi
reveal
alpha
viru
sinv
could
activ
perk
within
h
infect
vitro
studi
sinv
uncontrol
activ
upr
phosphoryl
lead
apoptosi
rathor
et
al
moreov
sinv
shown
promot
autophagi
neuron
cell
vitro
vivo
probabl
via
activ
upr
pathway
thu
limit
spread
viral
infect
orvedahl
et
al
shi
luo
one
way
inhibit
upr
small
molecul
inhibitor
repress
cellular
proteasom
machineri
exampl
use
pharmacolog
agent
inhibit
proteasom
like
metformin
ricin
previous
shown
reduc
cellular
upr
lee
et
al
parikh
et
al
amanso
et
al
theriault
et
al
previous
shown
upregul
perk
gene
murin
liver
h
post
vector
administr
balakrishnan
et
al
effect
revers
anim
pretreat
metformin
mgkg
importantli
also
found
attenu
upr
respons
aav
also
inhibit
express
variou
inflammatori
cytokin
chemokin
like
chemokin
cc
motif
ligand
chemokin
cc
motif
ligand
chemokin
cc
motif
ligand
chemokin
cxc
motif
ligand
chemokin
cc
motif
ligand
chemokin
cc
motif
receptor
chemokin
cxc
motif
ligand
balakrishnan
et
al
thu
inhibit
upr
proteasom
repressor
could
potenti
reduc
innat
immun
respons
aav
lead
higher
probabl
persist
gene
express
howev
known
fact
system
administr
proteasom
inhibitor
advers
effect
rajkumar
et
al
howev
conceiv
transient
inhibit
upr
pathway
prior
gene
transfer
initi
period
viral
infect
might
lead
improv
gene
transfer
effici
anoth
way
repress
upr
could
use
silenc
si
rna
specif
compon
upr
pathway
studi
previous
shown
modest
increas
transgen
express
aav
vector
perk
pathway
inhibit
specif
sirna
vitro
balakrishnan
et
al
shrna
upr
compon
also
potenti
test
vivo
shrna
deliv
induc
promot
avoid
advers
effect
caus
long
term
suppress
upr
machineri
avoid
immun
mediat
clearanc
viral
vector
gene
therapi
ideal
vector
dose
kept
minimum
would
allow
vector
escap
host
immun
surveil
enter
target
cell
may
also
reduc
cellular
stress
end
vector
bioengin
becom
import
tool
novel
optim
vector
creat
describ
earlier
aav
markus
et
al
qiao
et
al
gabriel
et
al
sen
et
al
b
achiev
effici
gene
transfer
lower
vector
dose
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
